Advances in AI-driven applications of metal-organic frameworks for the diagnosis and treatment of pancreatic cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Cancer statistics10.3322/caac.21654 ↗
2. Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the cancer incidence in five continents database10.1136/bmjgast-2024-001544 ↗
3. Long-term trends in the incidence and relative survival of pancreatic cancer in Canada: a population-based study10.1016/j.pan.2015.12.180 ↗
4. Cancer statistics
5. Surgical management of pancreatic cancer
6. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention10.1053/j.gastro.2023.02.012 ↗
7. Zhu · 2001
8. Pathological changes in pancreatic carcinogenesis: a review10.3390/cancers13040686 ↗
9. Theranostic nanoscale coordination polymers for magnetic resonance imaging and bisphosphonate delivery10.1039/C4TB00751D ↗
10. Survey of cancellation rate of hypertensive patients undergoing anaesthesia and elective surgery10.1093/bja/86.6.789 ↗
11. Undertreatment of pancreatic cancer: role of surgical pathology10.1245/s10434-020-09043-y ↗
12. Evaluation of the cytotoxic and immunomodulatory effects of sonodynamic therapy in human pancreatic cancer spheroids10.1016/j.jphotobiol.2024.112842 ↗
13. Mesoporous SiO2 based nanocomplex enzymes for enhanced chemodynamic therapy of pancreatic tumors10.1039/D4NR02406K ↗
14. Interventional photothermal therapy enhanced brachytherapy: a new strategy to fight deep pancreatic cancer
15. Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer10.1016/j.jconrel.2021.07.020 ↗
16. Acquired resistance to immunotherapy in MMR-D pancreatic cancer10.1186/s40425-018-0448-1 ↗
17. EGFR-Targeted and gemcitabine-incorporated chemogene for combinatorial pancreatic cancer treatment10.1007/s12274-023-6245-2 ↗
18. Two transition metal-organic frameworks based on 5-phenyl-isophthalate and N-donor mixed ligands: structure, magnetic, drug delivery and catalytic properties10.1016/j.jssc.2022.123175 ↗
19. Metal-organic framework (MOF)-based drug/cargo delivery and cancer therapy10.1002/adma.201606134 ↗
20. A hydroxyl-functionalized 3D porous gadolinium-organic framework platform for drug delivery, imaging and gas separation10.1016/j.jssc.2020.121544 ↗
21. A hydrostable anionic zinc-organic framework carrier with a bcu topology for drug delivery10.1039/C7CE01238A ↗
22. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
23. Sonodynamic therapy of NRP2 monoclonal antibody-guided MOFs@COF targeted disruption of mitochondrial and endoplasmic reticulum homeostasis to induce autophagy-dependent ferroptosis10.1002/advs.202303872 ↗
24. Advances in nanomaterial-mediated photothermal cancer therapies: toward clinical applications10.3390/biomedicines9030305 ↗
25. Interactions between tumor biology and targeted nanoplatforms for imaging applications10.1002/adfm.201910402 ↗
26. Aptamer-functionalized metal-organic frameworks (MOFs) for biosensing10.1016/j.bios.2020.112947 ↗
27. Exosome metabolic patterns on aptamer-coupled polymorphic carbon for precise detection of early gastric cancer10.1021/acsnano.2c05355 ↗
28. Hypoxia-Adapted sono-chemodynamic treatment of orthotopic pancreatic carcinoma using copper metal-organic frameworks loaded with an ultrasound-induced free radical initiator10.1021/acsami.1c11017 ↗
29. Intrinsic nucleus-targeted ultra-small metal-organic framework for the type I sonodynamic treatment of orthotopic pancreatic carcinoma10.1186/s12951-021-01060-7 ↗
30. Tablet-like TiO2/C nanocomposites for repeated type I sonodynamic therapy of pancreatic cancer10.1016/j.actbio.2021.05.029 ↗
31. A nanoscale Metal-organic framework to mediate photodynamic therapy and deliver CpG oligodeoxynucleotides to enhance antigen presentation and cancer immunotherapy10.1002/anie.201911429 ↗
32. Advances for managing pancreatic cystic lesions: integrating imaging and AI innovations10.3390/cancers16244268 ↗
33. The application of artificial intelligence in EUS10.1097/eus.0000000000000053 ↗
34. Hyperpolarized magnetic resonance and artificial intelligence: frontiers of imaging in pancreatic cancer
35. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
36. Pancreatic cancer10.1038/nrdp.2016.22 ↗
37. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men10.1002/cncr.23610 ↗
38. Pancreatic cancer: advances and challenges10.1016/j.cell.2023.02.014 ↗
39. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
40. Antitumor agents based on metal–organic frameworks10.1002/ange.202102574 ↗
41. Metal-organic frameworks for separations10.1021/cr200190s ↗
42. Metal–organic frameworks for separations10.1021/cr200190s ↗
43. The uptake of metal-organic frameworks: a journey into the cell10.1039/D0CS01414A ↗
44. A new Eu-MOF for ratiometrically fluorescent detection toward quinolone antibiotics and selective detection toward tetracycline antibiotics10.1016/j.cclet.2021.08.095 ↗
45. High throughput and noninvasive exosomal PD-L1 detection for accurate immunotherapy response prediction via Tim4-Functionalized magnetic core-shell metal-organic frameworks10.1021/acs.analchem.3c04117 ↗
46. A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO210.1039/C8SC04197K ↗
47. Serological exosome metabolic biopsy of hepatocellular carcinoma via designed core-shell nanoparticles
48. Accelerated exosomal metabolic profiling enabled by robust on‐target array sintering with metal-organic frameworks
49. Prospects for point-of-care pathogen diagnostics using surface-enhanced Raman scattering (SERS)10.1039/C5CS00828J ↗
50. Metal carbonyl-gold nanoparticle conjugates for live‐cell SERS imaging10.1002/anie.201204349 ↗
51. Improved performance of the pyrimidine-modified porous In-MOF and an in situ prepared composite ag@ In-MOF material10.1039/D2CC02639B ↗
52. IRTIDP: a simple integrated real-time isolation and detection platform for small extracellular vesicles Glypican-1 in pancreatic cancer patients10.1016/j.talanta.2024.126766 ↗
53. Pancreatic cancer surveillance: learning as we go10.1038/ajg.2011.68 ↗
54. Cancer of the pancreas: the best image for early detection-CT, MRI, PET or US?10.1155/2002/184370 ↗
55. Which is the best imaging method in pancreatic adenocarcinoma diagnosis and staging-CT, MRI or EUS?
56. Polymer/metal organic framework (MOF) nanocomposites for biomedical applications10.3390/molecules25010185 ↗
57. The applications of metal-organic-frameworks in controlled release of drugs
58. Metal‐organic‐frameworks as contrast agents in magnetic resonance imaging10.1002/cben.201600027 ↗
59. Chemically modified calcium phosphates as novel materials for bisphosphonate delivery10.1002/adma.200306340 ↗
60. Self-assembly nanoparticles for the delivery of bisphosphonates into tumors10.1016/j.ijpharm.2010.10.046 ↗
61. Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes10.1016/j.nano.2011.03.004 ↗
62. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity10.1016/j.jconrel.2013.02.003 ↗
63. Nanoscale coordination polymers for platinum-based anticancer drug delivery10.1021/ja803383k ↗
64. Lipid-coated nanoscale coordination polymers for targeted cisplatin delivery10.1039/c3ra42033g ↗
65. Lipid-coated nanoscale coordination polymers for targeted delivery of antifolates to cancer cells10.1039/C1SC00499A ↗
66. Phosphoresent nanoscale coordination polymers as contrast agents for optical imaging10.1002/anie.201008277 ↗
67. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging10.1021/ja803777x ↗
68. Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents J10.1021/ja0627444 ↗
69. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
70. Near-infrared fluorophores for biomedical imaging10.1038/s41551-016-0010 ↗
71. Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy10.1016/j.cdtm.2019.11.001 ↗
72. MOF-based biosensors for the detection of carcinoembryonic antigen: a concise review10.3390/molecules28165970 ↗
73. MicroRNAs: genomics, biogenesis, mechanism, and function10.1016/S0092-8674(04)00045-5 ↗
74. The role of MicroRNAs in human cancer
75. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis10.1007/s10620-010-1285-3 ↗
76. Prognostic impact of perioperative CA19-9 levels in patients with resected perihilar cholangiocarcinoma10.3390/jcm10071345 ↗
77. Gallic acid functionalized UiO-66 for the recovery of ribosylated metabolites from human urine samples10.1016/j.talanta.2019.03.072 ↗
78. AuNPs-NH2/Cu-MOF modified glassy carbon electrode as enzyme-free electrochemical sensor detecting H2O210.1016/j.jelechem.2019.113592 ↗
79. Metal-organic framework composites as electrocatalysts for electrochemical sensing applications10.1016/j.ccr.2017.11.028 ↗
80. Photoluminescent metal-organic frameworks and their application for sensing biomolecules10.1039/C9TA07022B ↗
81. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals10.1016/j.canlet.2016.03.042 ↗
82. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
83. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
84. Ultrathin two-dimension metal-organic framework nanosheets/multi-walled carbon nanotube composite films for the electrochemical detection of H2O210.1016/j.jelechem.2019.01.030 ↗
85. Magnetic porous carbon nanocomposites derived from metal-organic frameworks as a sensing platform for DNA fluorescent detection10.1016/j.aca.2016.08.024 ↗
86. Smartphone-assisted robust enzymes@MOFs-based paper biosensor for point-of-care detection10.1016/j.bios.2020.112095 ↗
87. Chapter 11 - graphene–metal–organic framework-modified electrochemical sensors10.1016/B978-0-12-815394-9.00011-X ↗
88. Tellurium doped zinc imidazole framework (Te@ZIF-8) for quantitative determination of hydrogen peroxide from serum of pancreatic cancer patients
89. A double reaction system induced electrochemiluminescence enhancement based on SnS2 QDs@MIL-101 for ultrasensitive detection of CA24210.1016/j.talanta.2022.123575 ↗
90. Nanomaterials-based sensitive electrochemiluminescence biosensing10.1016/j.nantod.2016.12.013 ↗
91. Multivalent aptamer-modified DNA origami as drug delivery system for targeted cancer therapy10.1007/s40242-019-9273-4 ↗
92. Special issue of "DNA Nanotechnology"10.1002/cjoc.201690008 ↗
93. SnS2 quantum dots as new emitters with strong electrochemiluminescence for ultrasensitive antibody detection10.1021/acs.analchem.8b03623 ↗
94. Metal-organic frameworks-based sensitive electrochemiluminescence biosensing10.1016/j.bios.2020.112332 ↗
95. Design of hierarchical architectures in metal-oganic frameworks for catalysis and adsorption10.1021/acs.chemmater.0c02973 ↗
96. Metal–organic frameworks in heterogeneous catalysis: recent progress, new trends, and future perspectives10.1021/acs.chemrev.9b00685 ↗
97. Photoluminescence enhancement by light harvesting of metal–organic frameworks surrounding semiconductor quantum dots10.1021/acs.chemmater.0c03367 ↗
98. Strong electrochemiluminescence from MOF accelerator enriched quantum dots for enhanced sensing of trace cTnI10.1021/acs.analchem.7b05137 ↗
99. Potentialresolved differential electrochemiluminescence immunosensor for cardiac troponin I based on MOF-5-wrapped CdS quantum dot nanoluminophores10.1021/acs.analchem.0c03131 ↗
100. Recent advances in electrochemical immunosensors10.3390/s17040794 ↗